FTCM
ONCE

First Trust Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

First Trust Capital Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-37,205
Closed -$3.81M – 48
2019
Q2 		$3.81M Sell
37,205
-71,640
-66% -$7.73M 0.53% 19
2019
Q1 		$12.4M Buy
+108,845
New +$8M 3.39% 8

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

First Trust Capital Management's ONCE Position: Q3 2019 in Review

First Trust Capital Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 37,205 shares — an estimated $3.81M sold.

First Trust Capital Management first reported a position in ONCE in Q1 2019 and held it in 2 quarters. The position peaked at $12.4M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • First Trust Capital Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • First Trust Capital Management sold 37,205 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $3.81M.
  • First Trust Capital Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • First Trust Capital Management's Spark Therapeutics, Inc. Common Stock position peaked at $12.4M in Q1 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on First Trust Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.